Literature DB >> 20476927

C-reactive protein at the interface between innate immunity and inflammation.

Andres Peisajovich1, Lorraine Marnell, Carolyn Mold, Terry W Du Clos.   

Abstract

C-reactive protein (CRP), the prototypic acute-phase protein, increases rapidly in response to infection and inflammation. Although CRP was thought to be a passive, nonspecific marker of inflammation, recent studies indicate that CRP plays a key role in the innate immune system by recognizing pathogens and altered self determinants. Activation of complement and interaction with Fcgamma receptors by CRP provides a link between the innate and adaptive immune systems. Recent evidence suggests that CRP is a marker of atherosclerotic disease and may play a role in its induction. However, CRP has an anti-inflammatory role in autoimmune diseases, such as systemic lupus erythematosus. In this article, we review the biological mechanisms by which CRP exerts its effects on the immune system and discuss its role in infection, cardiovascular disease, malignancy and systemic lupus erythematosus.

Entities:  

Year:  2008        PMID: 20476927     DOI: 10.1586/1744666X.4.3.379

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  45 in total

1.  Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; David J Hammond; Antonio E Rusiñol; Lawrence A Potempa; Alok Agrawal
Journal:  Clin Chim Acta       Date:  2009-06-21       Impact factor: 3.786

2.  Distinct Fcγ receptors mediate the effect of serum amyloid p on neutrophil adhesion and fibrocyte differentiation.

Authors:  Nehemiah Cox; Darrell Pilling; Richard H Gomer
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

3.  Role of pre-procedural C-reactive protein level in the prediction of major adverse cardiac events in patients undergoing percutaneous coronary intervention: a meta-analysisof longitudinal studies.

Authors:  Singh-Baniya Bibek; Yong Xie; Jia-Jia Gao; Zhi Wang; Jing-Feng Wang; Deng-Feng Geng
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

4.  Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease.

Authors:  Melanie Uhde; Mary Ajamian; Xueting Li; Gary P Wormser; Adriana Marques; Armin Alaedini
Journal:  Clin Infect Dis       Date:  2016-09-01       Impact factor: 9.079

5.  Blood-borne metabolic factors in obesity exacerbate injury-induced gliosis.

Authors:  Hung Hsuchou; Abba J Kastin; Weihong Pan
Journal:  J Mol Neurosci       Date:  2012-03-04       Impact factor: 3.444

6.  C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations.

Authors:  Gulistan Karadeniz; Gulru Polat; Gunes Senol; Melih Buyuksirin
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

7.  Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications.

Authors:  Sumanta Dutta; Grant M Fullarton; Matthew J Forshaw; Paul G Horgan; Donald C McMillan
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

Review 8.  Consolidated and emerging inflammatory markers in coronary artery disease.

Authors:  Valter Lubrano; Silvana Balzan
Journal:  World J Exp Med       Date:  2015-02-20

9.  Therapeutic potential of phosphoethanolamine-bound C-reactive protein in atherosclerosis.

Authors:  Alok Agrawal
Journal:  Future Lipidol       Date:  2008-12

Review 10.  Maternal C-reactive protein and in vitro fertilization (IVF) cycles.

Authors:  Fatemeh Diba-Bagtash; Azizeh Farshbaf-Khalili; Alyeh Ghasemzadeh; Laura Lotz; Amir Fattahi; Mahnaz Shahnazi; Ralf Dittrich
Journal:  J Assist Reprod Genet       Date:  2020-08-15       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.